Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study.

IF 5.2 1区医学 Q1 PSYCHIATRY

Addiction Pub Date : 2025-02-25 DOI:10.1111/add.70018

Thomas James Santo, Antoine Chaillon, Natasha Martin, Matthew Hickman, Nicola Jones, Michael Farrell, Chrianna Bharat, Louisa Degenhardt, Annick Borquez

{"title":"Quantifying the impact of a large-scale opioid agonist treatment program on suicide prevention in New South Wales, Australia: A data-modeling study.","authors":"Thomas James Santo, Antoine Chaillon, Natasha Martin, Matthew Hickman, Nicola Jones, Michael Farrell, Chrianna Bharat, Louisa Degenhardt, Annick Borquez","doi":"10.1111/add.70018","DOIUrl":null,"url":null,"abstract":"Aims: This study aimed to quantify the population-level impact of a large-scale opioid agonist treatment (OAT) program on suicide-related mortality among people with opioid use disorder (OUD) in New South Wales (NSW), Australia.Design: This is the first study to use dynamic mathematical modeling to explore the population-level impact of OAT on suicide mortality. The study used a two-part approach. First, we analyzed cohort data (2001-2017) to calculate incidence rate ratios (IRRs) and other model parameters related to OAT and suicide risk. Second, findings were applied to model outputs to estimate suicides averted by the NSW OAT program (2001-2020).Setting and participants: A cohort of 46 845 individuals who received OAT between 2001 and 2017 in community and prison settings in New South Wales, Australia.Measurements: IRRs for suicide and other model parameters were calculated for individuals on versus off OAT in community and prison settings (2001-2017). These estimates, along with model outputs, were used to determine the number and proportion of suicides averted by the OAT program (2001-2020).Findings: Receiving OAT was associated with an IRR for suicide of 0.32 [95% confidence interval (CI) = 0.25-0.40] in the community and 0.34 (95% CI = 0.10-1.10) in prison for cohort data analyses (2001-2017). Between 2001 and 2020, the OAT program in NSW averted an estimated 338 suicides [95% credible interval (CrI) = 213-492), with 325 (95% CrI = 202-476) averted in the community and 13 (95% CrI = 0-46) in prison, corresponding to a 35% (95% CrI = 27%-43%) reduction in suicides among those accessing OAT.Conclusions: The opioid agonist treatment program in New South Wales, Australia, was associated with a 35% reduction in suicide mortality among individuals with opioid use disorder receiving treatment between 2001 and 2020, providing novel evidence of its population-level impact on suicide prevention.","PeriodicalId":109,"journal":{"name":"Addiction","volume":" ","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2025-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Addiction","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1111/add.70018","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}

引用次数: 0

Abstract

Aims: This study aimed to quantify the population-level impact of a large-scale opioid agonist treatment (OAT) program on suicide-related mortality among people with opioid use disorder (OUD) in New South Wales (NSW), Australia.

Design: This is the first study to use dynamic mathematical modeling to explore the population-level impact of OAT on suicide mortality. The study used a two-part approach. First, we analyzed cohort data (2001-2017) to calculate incidence rate ratios (IRRs) and other model parameters related to OAT and suicide risk. Second, findings were applied to model outputs to estimate suicides averted by the NSW OAT program (2001-2020).

Setting and participants: A cohort of 46 845 individuals who received OAT between 2001 and 2017 in community and prison settings in New South Wales, Australia.

Measurements: IRRs for suicide and other model parameters were calculated for individuals on versus off OAT in community and prison settings (2001-2017). These estimates, along with model outputs, were used to determine the number and proportion of suicides averted by the OAT program (2001-2020).

Findings: Receiving OAT was associated with an IRR for suicide of 0.32 [95% confidence interval (CI) = 0.25-0.40] in the community and 0.34 (95% CI = 0.10-1.10) in prison for cohort data analyses (2001-2017). Between 2001 and 2020, the OAT program in NSW averted an estimated 338 suicides [95% credible interval (CrI) = 213-492), with 325 (95% CrI = 202-476) averted in the community and 13 (95% CrI = 0-46) in prison, corresponding to a 35% (95% CrI = 27%-43%) reduction in suicides among those accessing OAT.

Conclusions: The opioid agonist treatment program in New South Wales, Australia, was associated with a 35% reduction in suicide mortality among individuals with opioid use disorder receiving treatment between 2001 and 2020, providing novel evidence of its population-level impact on suicide prevention.

查看原文本刊更多论文

量化大规模阿片类激动剂治疗计划对澳大利亚新南威尔士州预防自杀的影响：数据建模研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Addiction 医学-精神病学

CiteScore

10.80

自引率

6.70%

发文量

319

审稿时长

3 months

期刊介绍： Addiction publishes peer-reviewed research reports on pharmacological and behavioural addictions, bringing together research conducted within many different disciplines. Its goal is to serve international and interdisciplinary scientific and clinical communication, to strengthen links between science and policy, and to stimulate and enhance the quality of debate. We seek submissions that are not only technically competent but are also original and contain information or ideas of fresh interest to our international readership. We seek to serve low- and middle-income (LAMI) countries as well as more economically developed countries. Addiction’s scope spans human experimental, epidemiological, social science, historical, clinical and policy research relating to addiction, primarily but not exclusively in the areas of psychoactive substance use and/or gambling. In addition to original research, the journal features editorials, commentaries, reviews, letters, and book reviews.